Saturday, January 07, 2012 8:05:22 AM
GNOM - Research/DD summary & charts !
Complete Genomics, Inc., a life sciences company, develops and commercializes a DNA sequencing platform for human genome sequencing and analysis. Its Complete Genomics Analysis platform combines its proprietary human genome sequencing technology with informatics and data management software to provide customers with data that is ready to be used for genome-based research. The company's human genome sequencing services have applications in cancer research, Mendelian disease research, rare variant disease research, and clinical trial optimization. Its customers include academic and government research centers, and biopharmaceutical companies. The company was founded in 2005 and is headquartered in Mountain View, California.
Company's website: http://www.completegenomics.com/
Financial Reports: http://ir.completegenomics.com/financials.cfm
SEC filings: http://ir.completegenomics.com/sec.cfm
Nasdaq.com Stock Research - Analyst Summary
http://www.nasdaq.com/symbol/gnom/analyst-research
Contacts
Investor Relations Contact:
Scott Sandler
Director, Financial Planning & Analysis
Complete Genomics, Inc.
ssandler@completegenomics.com
650.943.2788
GNOM Chart
Complete Genomics, Inc., a life sciences company, develops and commercializes a DNA sequencing platform for human genome sequencing and analysis. Its Complete Genomics Analysis platform combines its proprietary human genome sequencing technology with informatics and data management software to provide customers with data that is ready to be used for genome-based research. The company's human genome sequencing services have applications in cancer research, Mendelian disease research, rare variant disease research, and clinical trial optimization. Its customers include academic and government research centers, and biopharmaceutical companies. The company was founded in 2005 and is headquartered in Mountain View, California.
Company's website: http://www.completegenomics.com/
Financial Reports: http://ir.completegenomics.com/financials.cfm
SEC filings: http://ir.completegenomics.com/sec.cfm
Nasdaq.com Stock Research - Analyst Summary
http://www.nasdaq.com/symbol/gnom/analyst-research
Contacts
Investor Relations Contact:
Scott Sandler
Director, Financial Planning & Analysis
Complete Genomics, Inc.
ssandler@completegenomics.com
650.943.2788
GNOM Chart
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
